Inactive Instrument

WuXi PharmaTech (Cayman) Inc. (ADR) Share Price

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

WuXi PharmaTech Cayman : LabNetwork Forges eCommerce Alliances with Leading Chemical Providers	27/16/27	PU
WuXi PharmaTech Cayman : AppTec Congratulates MSD on Receiving FDA Approval of Zepatier	05/16/05	PU
WuXi PharmaTech Cayman : AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement	12/16/12	PU
WuXi PharmaTech Cayman : AppTec Plans $120 Million Investment in New Integrated Biologics Solution Center to Expedite Biologics Development from Ideas to Clinic	12/16/12	PU
WuXi PharmaTech Cayman : and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in China	16/15/16	PU

07/15/07

Managers	Title	Age	Since
Xiao Zhong Liu FOU	Founder	60	01/00/01
Zhao Hui Zhang FOU	Founder	54	01/00/01
Ge Li CEO	Chief Executive Officer	56	01/00/01

Members of the board	Title	Age	Since
Ge Li CEO	Chief Executive Officer	56	01/00/01
Zhao Hui Zhang FOU	Founder	54	01/00/01
Xiao Zhong Liu FOU	Founder	60	01/00/01

Sector

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B